Belgium refuses reimbursement for obesity drug Mounjaro, following Wegovy precedent

Belgian Health Minister Frank Vandenbroucke declined to reimburse the obesity drug Mounjaro, citing cost concerns, after previously rejecting Wegovy. The decision affects patient access and signals continued fiscal restraint in public health spending, though the specific rationale remains partially undisclosed.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works